FINAL PROGRAM - American Society of Gene & Cell Therapy
FINAL PROGRAM - American Society of Gene & Cell Therapy
FINAL PROGRAM - American Society of Gene & Cell Therapy
- No tags were found...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
54<strong>American</strong> <strong>Society</strong> <strong>of</strong> <strong>Gene</strong> & <strong>Cell</strong> <strong>Therapy</strong>Program ScheduleFriday, May 21Friday, May 21 stPlenary Abstract Session 3008:00 am - 10:00 amRoom: Marriott Ballroom Salons 1, 2 & 3Top Oral Abstracts Plenary SessionCo-ChairsStanton L. Gerson, MD & John J. Rossi, PhDSpeakersMervin C. Yoder, MD IntroducesEirini P. Papapetrou, MD, PhDTherapeutic Transgene Expression in Patient-Specific iPS <strong>Cell</strong>s after Selection <strong>of</strong> “Safe Harbors” for Lentiviral Vector IntegrationJames Ellis, PhD IntroducesAxel Schambach, MD PhDA Novel Lentiviral Expression System Reveals Patchwork Colony Formation during Reprogramming to Induced Pluripotent Stem <strong>Cell</strong>sDieter C. Gruenert, PhD IntroducesErica B. Schleifman, BSTargeted Genomic Modification and Inactivation <strong>of</strong> the CCR5 <strong>Gene</strong> Using PNA-Induced Homologous RecombinationMatthew H. Porteus, MD, PhD IntroducesRichard Gabriel, Dipl.-Biol.Lentiviral Microarrays for High-Throughput and Real-Time Monitoring <strong>of</strong> <strong>Gene</strong> Expression DynamicsBruce Sullenger, PhD IntroducesJiehua Zhou, PhDSystemic Administration <strong>of</strong> Sendrimer- and Aptamer-siRNA Conjugates Efficiently Suppresses HIV-1 InfectionChiara Bonini, MD IntroducesAntonio Di Stasi, MDCASPALLO: Phase I Clinical Trial <strong>of</strong> Allodepleted T <strong>Cell</strong>s Transduced with Inducible Caspase 9 Suicide <strong>Gene</strong> after Haploidentical Stem <strong>Cell</strong> TransplantationBreak10:00 am – 10:30 amScientific Symposium 31010:30 am - 12:30 pmRoom: Virginia SuitePersonalized <strong>Cell</strong> and <strong>Gene</strong> <strong>Therapy</strong>ChairJohn J. Nemunaitis, MDSpeakersJohn J. Nemunaitis, MDSuccess <strong>of</strong> <strong>Gene</strong> <strong>Therapy</strong> - A Personalized and Personal ApproachClinical use <strong>of</strong> molecular science is coming <strong>of</strong> age! Numerous targeted therapies, many related to gene based technology, in particular involving RNA interference platforms,are undergoing clinical track development. Mechanisms for cancer specific plasmid delivery are unfolding in the clinical arena. Furthermore, gene based vaccinesare showing improved promise. These dynamics combined with more efficient and economic quantitative proteogenomic technology development will enable a personalizedapproach to cancer therapy. Results <strong>of</strong> personalized gene and cell based therapies will be discussed.EXHIBITOR PROSPECTUSfinal program
Change language